You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Litigation Details for United States v. Holmes (N.D. Cal. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Biologic Drugs cited in United States v. Holmes
The biologic drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for United States v. Holmes (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2021-09-07 1002 Exhibit List USP 10,522,245 HOLMES005214 HOLMES005301… Perkins Coie Presentation: Theranos, Inc. Patent Portfolio PC0000048 … D. Taylor Email to A. Shah et al. re Theranos Patent List (with FIG00000703 FIG00000778…"Boies Schiller & Flexner Adds Two Top Patent Litigators" HOLMES002431 HOLMES002433 External link to document
2022-11-10 1642 Exhibit H US 9,529,976 …Agreement Theranos’ US Patent Portfolio Is Young Theranos has a young patent portfolio, with US expiration…Detection Technology Patents Theranos’ core technologies enjoy robust patent protection … Patent Coverage Technology Patent Coverage … US Patent Classification US Patent Classification External link to document
2022-11-12 1645 Exhibits 2,819,163 8.9% 6.6% 6,660,267 3,841,104 37.0% … all assets of the Company including its patents and patent applications 5. Fortress made this loan… 169,583 Legal Regulatory and Patents Costs 313,058 100% … 43,792 Legal Regulatory and Patents Costs 1,750,963 100% … 169,583 Legal Regulatory and Patents Costs 313,058 100% External link to document
2022-11-19 1655 Exhibit M (Previously filed under seal) 2,819,163 8.9% 6.6% 6,660,267 3,841,104 37.0% … all assets of the Company including its patents and patent applications5. Fortress made this loan… Legal Regulatory and Patents Costs 313,058 … Legal Regulatory and Patents Costs 1.750,963 … Legal Regulatory and Patents Costs 313,058 100% External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.